UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial

Journal of clinical oncology, 2017-10, Vol.35 (28), p.3222-3229

2017

Volltextzugriff (PDF)

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Clinical cancer research, 2021-09, Vol.27 (18), p.5123-5130

2021

Volltextzugriff (PDF)

Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance

Journal of proteome research, 2021-05, Vol.20 (5), p.2983-3001

2021

Volltextzugriff (PDF)

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning

Nature communications, 2023-04, Vol.14 (1), p.1968-1968, Article 1968

2023

Volltextzugriff (PDF)

Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors

Breast cancer research : BCR, 2018-07, Vol.20 (1), p.64-64, Article 64

2018

Volltextzugriff (PDF)

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer

PloS one, 2020, Vol.15 (4), p.e0231786-e0231786

2020

Volltextzugriff (PDF)

The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target

JNCI : Journal of the National Cancer Institute, 2019-03, Vol.111 (3), p.301-310

2019

Volltextzugriff (PDF)

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer

Journal of clinical oncology, 2019-12, Vol.37 (35), p.3340-3349

2019

Volltextzugriff (PDF)

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer

Nature communications, 2021-07, Vol.12 (1), p.4601-4601, Article 4601

2021

Volltextzugriff (PDF)

Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial

Journal of clinical oncology, 2019-05, Vol.37 (14), p.1179-1187

2019

Volltextzugriff (PDF)

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

Molecular oncology, 2022-07, Vol.16 (13), p.2451-2469

2022

Volltextzugriff (PDF)

A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery

Journal of proteome research, 2015-07, Vol.14 (7), p.2807-2818

2015

Volltextzugriff (PDF)

Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up

British journal of cancer, 2022-05, Vol.126 (8), p.1145-1156

2022

Volltextzugriff (PDF)

Machine Learning & Molecular Radiation Tumor Biomarkers

Seminars in radiation oncology, 2023-07, Vol.33 (3), p.243-251

2023

Volltextzugriff (PDF)

Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast‐conserving surgery: a long‐term follow‐up of the SweBCG91‐RT randomised trial

Molecular oncology, 2020-11, Vol.14 (11), p.2713-2726

2020

Volltextzugriff (PDF)

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial

Clinical cancer research, 2023-05, Vol.29 (9), p.1783-1793

2023

Volltextzugriff (PDF)

The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

Cancer research (Chicago, Ill.), 2023-08, Vol.83 (16), p.2763-2774

2023

Volltextzugriff (PDF)

Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer

European urology, 2023-10, Vol.84 (4), p.437-438

2023

Volltextzugriff (PDF)

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2022-12, Vol.28 (24), p.5396-5404

2022

Volltextzugriff (PDF)

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

Journal for immunotherapy of cancer, 2023-05, Vol.11 (5), p.e006618

2023

Volltextzugriff (PDF)

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

Clinical cancer research, 2017-11, Vol.23 (22), p.7072-7083

2017

Volltextzugriff (PDF)

Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial

Clinical cancer research, 2021-02, Vol.27 (3), p.749-758

2021

Volltextzugriff (PDF)

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer

Clinical epigenetics, 2022-05, Vol.14 (1), p.60-60, Article 60

2022

Volltextzugriff (PDF)

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

European urology, 2021-06, Vol.79 (6), p.717-721

2021

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(159)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning

Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer

The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer

Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery

Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up

Machine Learning & Molecular Radiation Tumor Biomarkers

Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast‐conserving surgery: a long‐term follow‐up of the SweBCG91‐RT randomised trial

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial

The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence

Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

Suchergebnisse filtern